NovaBridge Biosciences (NBP) Gains from Equity Investments (2019)
NovaBridge Biosciences (NBP) posted quarterly Gains from Equity Investments of -$26531.7 for Q4 2019.
NovaBridge Biosciences (NBP) Gains from Equity Investments (2019) Analysis & Trends
NovaBridge Biosciences (NBP) has reported Gains from Equity Investments for 1 consecutive years, with -$26531.7 the latest figure, recorded in Q4 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,019.86 Bn | 66,019.58 Bn | - |
| 2 | Nanobiotix | 1,909.20 Bn | 1,909.14 Bn | - |
| 3 | Akari Therapeutics | 1,009.43 Bn | 1,009.43 Bn | - |
| 4 | BeOne Medicines | 468.20 Bn | 463.41 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 122.50 Bn | 115.26 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.15 Bn | 61.39 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.66 Bn | 62.66 Bn | - |
| 8 | Argenx Se | 55.58 Bn | 50.39 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.43 Bn | 34.43 Bn | 959.66 Mn |
| 10 | NovaBridge Biosciences | 399.77 Mn | 399.77 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2019 | -26,531.70 |
| Dec 31, 2019 | -26,531.70 |